Frontiers in Cardiovascular Medicine (Mar 2022)

The Role of Interleukin-6 Family Members in Cardiovascular Diseases

  • Yongqi Feng,
  • Yongqi Feng,
  • Yongqi Feng,
  • Di Ye,
  • Di Ye,
  • Di Ye,
  • Zhen Wang,
  • Zhen Wang,
  • Zhen Wang,
  • Heng Pan,
  • Heng Pan,
  • Heng Pan,
  • Xiyi Lu,
  • Xiyi Lu,
  • Xiyi Lu,
  • Menglong Wang,
  • Menglong Wang,
  • Menglong Wang,
  • Yao Xu,
  • Yao Xu,
  • Yao Xu,
  • Junping Yu,
  • Junping Yu,
  • Junping Yu,
  • Jishou Zhang,
  • Jishou Zhang,
  • Jishou Zhang,
  • Mengmeng Zhao,
  • Mengmeng Zhao,
  • Mengmeng Zhao,
  • Shuwan Xu,
  • Shuwan Xu,
  • Shuwan Xu,
  • Wei Pan,
  • Wei Pan,
  • Wei Pan,
  • Zheng Yin,
  • Zheng Yin,
  • Zheng Yin,
  • Jing Ye,
  • Jing Ye,
  • Jing Ye,
  • Jun Wan,
  • Jun Wan,
  • Jun Wan

DOI
https://doi.org/10.3389/fcvm.2022.818890
Journal volume & issue
Vol. 9

Abstract

Read online

Cardiovascular disease is one of the main causes of human mortality. Cytokines play crucial roles in the development of cardiovascular disease. Interleukin (IL)-6 family members are a series of cytokines, including IL-6, IL-11, IL-30, IL-31, OSM, LIF, CNTF, CT-1, CT-2, and CLC, that regulate multiple biological effects. Experimental and clinical evidence shows that IL-6 family members are closely related to cardiovascular diseases such as atherosclerosis, hypertension, aortic dissection, cardiac fibrosis, and cardiomyopathy. This review mainly discusses the role of IL-6 family members in cardiovascular disease for the sake of identifying possible intervention targets for cardiovascular disease prevention and treatment.

Keywords